Literature DB >> 15862989

Stereocontrolled synthesis of anticancer beta-lactams via the Staudinger reaction.

Bimal K Banik1, Indrani Banik, Frederick F Becker.   

Abstract

Stereocontrolled synthesis of novel beta-lactams using polyaromatic imines following the Staudinger reaction has been accomplished. The effects of domestic microwave irradiation on this type of reaction have been investigated. Formation of trans-beta-lactams has been explained through isomerization of the enolates formed during the reaction of acid chloride (equivalent) with imines in the presence of triethylamine. A donor-acceptor complex pathway is believed to be involved in the formation of cis-beta-lactams. The effect of a peri hydrogen has been found to be significant in controlling the stereochemistry of the resulting beta-lactams. SAR has identified beta-lactams with anticancer activity. The presence of an acetoxy group has proven obligatory for their anticancer activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862989     DOI: 10.1016/j.bmc.2005.03.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Polycyclic aromatic compounds as anticancer agents: Evaluation of synthesis and in vitro cytotoxicity.

Authors:  Debasish Bandyopadhyay; Jose C Granados; John D Short; Bimal K Banik
Journal:  Oncol Lett       Date:  2011-10-04       Impact factor: 2.967

2.  A personal perspective on medicinal and pharmaceutical chemistry.

Authors:  Bimal K Banik
Journal:  Front Chem       Date:  2014-02-27       Impact factor: 5.221

3.  An expeditious iodine-catalyzed synthesis of 3-pyrrole-substituted 2-azetidinones.

Authors:  Debasish Bandyopadhyay; Jessica Cruz; Ram N Yadav; Bimal K Banik Banik
Journal:  Molecules       Date:  2012-09-28       Impact factor: 4.411

4.  Stereochemical preference toward oncotarget: Design, synthesis and in vitro anticancer evaluation of diastereomeric β-lactams.

Authors:  Fabián Olazarán-Santibáñez; Debasish Bandyopadhyay; Pilar Carranza-Rosales; Gildardo Rivera; Isaías Balderas-Rentería
Journal:  Oncotarget       Date:  2017-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.